Milad Abbasi

1.4k citations
38 papers · 1.0k indexed · h-index 20
Topics
MXene and MAX Phase Materials (13 papers)Graphene and Nanomaterials Applications (12 papers)Nanoplatforms for cancer theranostics (11 papers)
Partner nations
IranIndiaMalaysia

In The Last Decade

Milad Abbasi

37 papers receiving 1000 citations

Peers

Milad Abbasi
Comparison fields: 5 of 113
  • Materials Chemistry 457
  • Biomedical Engineering 413
  • Biomaterials 234
  • Molecular Biology 213
  • Organic Chemistry 91
Replace Mozhgan Abasi with:
Mozhgan Abasi Iran
Jaydeep Bhattacharya India
Nagaprasad Puvvada India
Simona Bettini Italy
Varsha Brahmkhatri India
Sevda Jafari Iran
Arezoo Khosravi Iran
Youbei Qiao China
Renu Geetha Bai Estonia
Xiuli Ren China
Milad Abbasi relative to Mozhgan Abasi Iran Mozhgan Abasi's profile →
Citations per field
00.5×10×12.5×
Mozhgan Abasi · 1×
Citations per year

Countries citing papers authored by Milad Abbasi

Since Specialization
Citations

This map shows the geographic impact of Milad Abbasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milad Abbasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milad Abbasi more than expected).

Fields of papers citing papers by Milad Abbasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milad Abbasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milad Abbasi. The network helps show where Milad Abbasi may publish in the future.

Co-authorship network of co-authors of Milad Abbasi

This figure shows the co-authorship network connecting the top 25 collaborators of Milad Abbasi. A scholar is included among the top collaborators of Milad Abbasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milad Abbasi. Milad Abbasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 7
2 19
3 4
4 7
5 1
6 3
7 3
8 23
9 21
10 50
11 25
12 12
13 78
14 29
15 50
16 37
17 91
18 45
19 17
20 14

About Milad Abbasi

Milad Abbasi is a scholar working on Biomedical Engineering, Biomaterials and Materials Chemistry, having authored 38 papers that have together received 1.0k indexed citations. Recurring topics across this work include MXene and MAX Phase Materials (13 papers), Graphene and Nanomaterials Applications (12 papers) and Nanoplatforms for cancer theranostics (11 papers). The work is most often cited by research in Biomaterials (234 citations), Molecular Medicine (70 citations) and Materials Chemistry (457 citations). Milad Abbasi has collaborated with scholars based in Iran, India and Malaysia. Frequent co-authors include Ahmad Vaez, Sareh Mosleh-Shirazi, Ali Mohammad Amani, Hesam Kamyab, Seyed Reza Kasaee, Shreeshivadasan Chelliapan, Mostafa Shafiee, Ehsan Vafa, Lobat Tayebi and Ali Mohammad Amani. Their work appears in journals such as Journal of Cleaner Production, Scientific Reports and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026